CH331998A - Process for the preparation of 3-keto-oxysteroids - Google Patents
Process for the preparation of 3-keto-oxysteroidsInfo
- Publication number
- CH331998A CH331998A CH331998DA CH331998A CH 331998 A CH331998 A CH 331998A CH 331998D A CH331998D A CH 331998DA CH 331998 A CH331998 A CH 331998A
- Authority
- CH
- Switzerland
- Prior art keywords
- keto
- enamine
- steroids
- oxysteroids
- dione
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 claims description 5
- 229960005471 androstenedione Drugs 0.000 claims description 5
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- 229960003604 testosterone Drugs 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 claims 3
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 9
- -1 lithium aluminum hydride Chemical compound 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 150000002081 enamines Chemical class 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 5
- 150000003335 secondary amines Chemical class 0.000 description 5
- 150000003431 steroids Chemical class 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 125000005265 dialkylamine group Chemical group 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- XMRPGKVKISIQBV-UHFFFAOYSA-N (+-)-5- Pregnane-3,20-dione Natural products C1CC2CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 XMRPGKVKISIQBV-UHFFFAOYSA-N 0.000 description 1
- CBMYJHIOYJEBSB-UHFFFAOYSA-N (10S)-3t.17t-Dihydroxy-10r.13c-dimethyl-(5cH.8cH.9tH.14tH)-hexadecahydro-1H-cyclopenta[a]phenanthren Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)O)C4C3CCC21 CBMYJHIOYJEBSB-UHFFFAOYSA-N 0.000 description 1
- RAJWOBJTTGJROA-UHFFFAOYSA-N (5alpha)-androstane-3,17-dione Natural products C1C(=O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 RAJWOBJTTGJROA-UHFFFAOYSA-N 0.000 description 1
- AHRWWYGWQKBKBF-PCHYHQBZSA-N (5r,8s,9s,10s,13s,14s,17s)-17-acetyl-10,13-dimethyl-2,4,5,6,7,8,9,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-3,11-dione Chemical compound C([C@H]1CC2)C(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)C)[C@@]2(C)CC1=O AHRWWYGWQKBKBF-PCHYHQBZSA-N 0.000 description 1
- NCPARTAPRIYXAZ-MENMYXSPSA-N (8S,9S,10R,13S,14S)-10,13-dimethyl-3-pyrrolidin-1-yl-2,7,8,9,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-11,17-dione Chemical compound C[C@]12CC(=O)[C@H]3[C@@H](CC=C4C=C(CC[C@]34C)N3CCCC3)[C@@H]1CCC2=O NCPARTAPRIYXAZ-MENMYXSPSA-N 0.000 description 1
- RYMKCRPGXRRYQV-CWMMHYCISA-N (8r,9s,10r,13s,14s)-10,13-dimethyl-3-pyrrolidin-1-yl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-one Chemical compound C([C@@H]1[C@@H]([C@]2(CC3)C)CC[C@]4([C@H]1CCC4=O)C)C=C2C=C3N1CCCC1 RYMKCRPGXRRYQV-CWMMHYCISA-N 0.000 description 1
- MUMGGOZAMZWBJJ-XZIMXZIZSA-N (8r,9s,10r,13s,14s)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-XZIMXZIZSA-N 0.000 description 1
- LNGLEOIUQBVRRY-JYQHCDCXSA-N (8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,4,5,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene-3,6-dione Chemical compound C1C(=O)C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 LNGLEOIUQBVRRY-JYQHCDCXSA-N 0.000 description 1
- WKAVAGKRWFGIEA-DADBAOPHSA-N 11-Ketoprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2=O WKAVAGKRWFGIEA-DADBAOPHSA-N 0.000 description 1
- WKAVAGKRWFGIEA-UHFFFAOYSA-N 11-Ketoprogesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2=O WKAVAGKRWFGIEA-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- JFXDIXYFXDOZIT-UHFFFAOYSA-N 4-methoxy-n-methylaniline Chemical compound CNC1=CC=C(OC)C=C1 JFXDIXYFXDOZIT-UHFFFAOYSA-N 0.000 description 1
- RAJWOBJTTGJROA-WZNAKSSCSA-N 5alpha-androstane-3,17-dione Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 RAJWOBJTTGJROA-WZNAKSSCSA-N 0.000 description 1
- XMRPGKVKISIQBV-BJMCWZGWSA-N 5alpha-pregnane-3,20-dione Chemical compound C([C@@H]1CC2)C(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)C)[C@@]2(C)CC1 XMRPGKVKISIQBV-BJMCWZGWSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- LNGLEOIUQBVRRY-UHFFFAOYSA-N UNPD120079 Natural products C1C(=O)C2CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 LNGLEOIUQBVRRY-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- VMWZRHGIAVCFNS-UHFFFAOYSA-J aluminum;lithium;tetrahydroxide Chemical compound [Li+].[OH-].[OH-].[OH-].[OH-].[Al+3] VMWZRHGIAVCFNS-UHFFFAOYSA-J 0.000 description 1
- 150000003975 aryl alkyl amines Chemical class 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- LAWOZCWGWDVVSG-UHFFFAOYSA-N dioctylamine Chemical compound CCCCCCCCNCCCCCCCC LAWOZCWGWDVVSG-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- MJCJUDJQDGGKOX-UHFFFAOYSA-N n-dodecyldodecan-1-amine Chemical compound CCCCCCCCCCCCNCCCCCCCCCCCC MJCJUDJQDGGKOX-UHFFFAOYSA-N 0.000 description 1
- PXSXRABJBXYMFT-UHFFFAOYSA-N n-hexylhexan-1-amine Chemical compound CCCCCCNCCCCCC PXSXRABJBXYMFT-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 150000003128 pregnanes Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
Verfahren zur Herstellung von 3.Keto-oxysteroiden Das sehweiz. Patent Nr. 322242 bezieht sieh auf ein Verfahren zur Herstellung neuer Ena- minderivate von 3-Ketosteroiden, das dadurch Pekennzeiehnet ist, dass man ein 3-Keto-steroid mit einem sekundären Amin umsetzt.
Die Überführung von 3-Keto-steroiden in die I:naminderivate stellt ein wertvolles Ver fahren zur Blockierung der 3-Ketogruppe dar; die 3-Ketogruppe kann nach Durchführung weiterer Umwandlungen im Steroidmolekül durch einfache Hydrolyse leicht und mit hoher Ausbeute wieder regeneriert werden.
Gegenstand des vorliegenden Patentes ist nun ein Verfahren zur Herstellung von 3- Ket.o-oxysteroiden, das dadurch gekennzeich net ist, da.ss man 3-Keto-steroide, die minde stens eine weitere Carbonylgruppe im Mole kül enthalten, durch Umsetzung mit einem sekundären Amin, vorzugsweise Pyrrolidin, in die entsprechenden 3-Dnaminderivate über führt, in diesen die freien Carbonylgruppen zu Ilydroxylgruppen reduziert, vorzugsweise mit Lithium-Aluminilimhydxid,
und in den so erhaltenen Enaminderivaten die 3-Ketogruppe durch Hydrolyse wieder herstellt.
Wenn man Lithium-Aluminiumhydrid als Reduktionsmittel verwendet, so findet die Wiederherstellung der 3-Ketogruppe in der Regel gleichzeitig mit der Zerlegung der bei der Reduktion gebildeten Komplexverbindung statt.
So kann man zum Beispiel das physiolo gisch aktive Hormon Testosteron aus 4-Andro- sten-3,17-dion über das Enaminderivat her stellen, indem man das 4-Androsten-3,17-dion in das 3-(N-Pyrrolidyl)-3,5-androstadien-17- on überführt und in dem so geschützten Ke- ton die 17-Ketogruppe zur 17-Oxy-gruppe reduziert.
Regeneriert man anschliessend im 3-(N-Pyrrolidyl)-3,5-androstadien-17-ol die 3- Ketogruppe, so erhält man 4-Androsten-17-ol- 3-on, das heisst Testosteron. Bei Verwendung von 3-Keto-steroiden mit zusätzlichen Keto- gruppen an irgendeiner andern Stelle des Moleküls kann man in gleicher Weise vor gehen.
Die Ausgangsstoffe können im Kern wei tere Substituenten, wie z. B. Oxy-, Acyloxy-, Carbalkoxygruppen usw., tragen, die sich an einem oder mehreren der Kohlenstoffatome des Kernes, z. B. in Stellung 7, 11, 12, 17 oder andern Stellungen, befinden können. Ausser dem kann der Kern Doppelbindungen auf -eisen. Diese Doppelbindungen können iso liert oder konjugiert sein und können auch mit dem Carbonylsaiierstoffatom in 3-Stellung konjugiert sein.
Wenn 4(5)-Doppelbindung vorhanden ist, so verschiebt sich die 4(5)- Doppelbindung während der Reaktion in die 5 (6) -Stellung. In 17-Stellung des Kernes kann eine Seitenkette vorhanden sein, z. B. eine sol che, wie sie in natürlichen Steroiden, wie in den Sterinen, Gallensäuren und Pregnanen, vorkommt oder eine aus einer solchen durch Substition oder teilweisen Abbau erhaltene.
Beispiele von solchen als Ausgangsstoffe in Frage kommenden Ketosteroiden sind zum Beispiel Sterine, wie Cholestan-3,6-dion, 11- Keto-progesteron, Pregnan-3,20-dion, Pre- gnan-3,11,20-trion, Cortison, 21-Acyloxy-17a- oxy-pregnan-3,11,20-trion, Androstan-3,17- dion, 4-Androsten-3,17-dion.
Die Enaminderivate erhält man vorzugs weise durch Erhitzen des 3-Keto-steroids mit dem sekundären Amin in einem organischen Lösungsmittel unter fortlaufender Entfer nung des bei der Reaktion entstehenden Was sers. Das Wasser kann durch azeotrope De stillation oder mittels einer basischen, anorga nischen, Wasser bindenden Verbindung, wie Kaliumkarbonat, Caleium- oder Bariumoxyd und dergleichen, erfolgen.
Die Bildung sol cher Enamine erfolgt bei Temperaturen zwi schen etwa 25 und etwa 150 C, vorzugsweise zwischen 40 und 110 C, zweckmässig bei der Rückflusstemperatur des Reaktionsgemisches, doch stets unterhalb der Zersetzungstempera tur des EndprodLrktes, das heisst des Enamins. Die Reaktionszeit variiert je nach der Reak tionsfähigkeit des Amins und der Reaktions temperatur. Gewöhnlich ist im bevorzugten Temperaturbereich eine Reaktionszeit von 30 Minuten bis zu 20 Stunden vorteilhaft.
Die bevorzugte Menge des sekundären Amins ist 4 Mol Amin pro Mol Steroid; doch kann man allgemein mit. Mengen von etwa 1-20 Mol Amin oder mehr arbeiten. Als Lösungsmittel eignen sich Diäthyläther, Tetrahydrofuran, ein überschuss des Amins, Benzol, Xylol, To luol, Pentan, Ilexamin und dergleichen.
Zur Förderung der Reaktion und Erhö hung der Ausbeute kann man einen sauren Katalysator, wie p-Toluolsulfosäure, Naphtha- linsulfosäure, Schwefelsäure und dergleichen, zusetzen, wobei gewöhnlich die p-Toluolsulfo- säur e bevorzugt wird. Manchmal, besonders wenn das Amin schwer reagiert, kann man unter Anwendung von Druck in einer Bombe arbeiten.
Als sekundäre Amine kann man Dialkyl- amine, wie Diäthylamin, Dipropylamin, Di- butylamin, Dihexylamin, Diocty lamin und Di- dodecylamin; Cycloalkylamirie, wie Diey clo- hexylamin und dergleichen;
eyclische Amine, wie Piperidin, Pyrrolidin, Tetrahydroehinolin, Oxazolidin (Tetrahydrooxazol), llorpholirr und dergleichen; Aralkylalkylamine, wie N llethy 1-benzy lamin, N-Ätlryl-benzylamin und dergleichen; substituierte Dialkylamine, wie Diäthanolamin und dergleichen;
und Aryl- alkylamine wie. N-141ethyl-anilin, N-3lethyl- toluidin, N-Methyl-anisidin und dergleichen, verwenden.
<I>Beispiel.</I> a) Eine Lösung von 8,58g (0,3 Mol) 4- Androsten-3,17-dion und 10,02 cm3 (0,l2 Mol) Pyrrolidin in 150 em3 Benzol wird in einem, Kolben mit Rüekflusskübler und Wasserfän ger unter Rühren 3 Stunden kräftig am Rüek- fluss erhitzt, nach welcher Zeit die theoretische Menge Wasser aufgefangen worden ist.
Die Lösung wird dann im Vakuum zur Trockne eingedampft und der gelbe, kristalline Rüek- stand mit 50 cm3 Methanol verrieben. Nach sechsstündigem Kühlen bei 4 C wird filtriert, mit 23 em3 kaltem Methanol gewasehen und getrocknet.
Die Ausbeute an 3-(N-Pyrrolidyl)- 3,5-androstadien-17-on ist 9,15 g (90 /o). b) In einen Soxhlet-Kolben gibt man eine Lösung von 3,8 g (0,10 111o1) Lithium-Alumi- niumhydrid in 1600 em3 wasserfreiem Äther, und in die Extraktionspatron 6,09 g (0,018) hol) 3-(N-Pyrrolidyl)-3,
5-androstadien-17-on. Dann wird am Rückfluss erwärmt. Die kon densierten zurückfliessenden Dämpfe lösen das Steroid und bringen es in den Kolben, wo die Reduktion erfolgt. Nach 45 Minuten ist alles Steroid aufgelöst. Die Mischung wird gekühlt, durch Zugabe von 10 cm3 Wasser vorsichtig zersetzt und mit Benzol extrahiert. Die Ben- zollösung wird getrocknet und eingedampft.
Man erhält 5,25 g (86 "/m) rohes 3-(N-Pyrroli- dyl)-3,5-androstadien-17ss-ol. Eine aus Methy- lenchlorid-Methanol umkristallisierte Probe gibt gelbe Nadeln vom Schmelzpunkt 133 bis 137 C :Analyse: /oa berechnet für Cz3H35ON: N 4,13 gefunden:
N 4,07 e) Eine Lösung von 4,25 g 3-(N-Pyrroli- dyl)-3,5-androstadien-17ss-ol (hergestellt wie unter b beschrieben), 7,5 g -,atriumaeetat, 8 cin3 Wasser und 2 em3 konzentrierte Salz säure in 150 em3 Methanol -wird am Rückfloss :; Stunden gekocht. Die Lösun- wird hierauf mit 200 em3 Wasser verdünnt, abgekühlt und vom ausgefällten Testosteron abfiltriert. Letz teres wird mit.
Wasser gewaschen und get.rock- i)et. Die Ausbeute beträgt 2,04 g (73 %); Schmelzpunkt 149-150 C).
Gleieh wie im vorstehenden. Beispiel kann man, ausgehend von andern 3-Keto-steroiden mit zusätzlichen Carbonylgruppen, zu den entsprechenden 3-Keto-oxysteroiden gelangen, die an sieh bereits physiologisch aktive Ste- roidhormone sein können oder sieh in aktive Verbindungen überführen lassen.
So erhält man zum Beispiel aus 3-(N-Pyrrolidyl)-3,5- androstadien-11,17-dion und aus 3-(N-Pyrro- liclyl )-3,5-pregnadien-lla-ol-20-on durch Re duktion mit Lithium-Aluminiumhydrid oder andern Reduktionsmitteln und Wiederlierstel- lung der 3-Ketogruppe durch saure 11vdro- lyse das 11',-Oxv-testosteron bzw.
das 11a,20- I)ioxy -4-pregnen-3-on.
Process for the production of 3. keto-oxysteroids Das sehweiz. U.S. Patent No. 322242 relates to a process for the preparation of new enamine derivatives of 3-keto steroids which is characterized by reacting a 3-keto steroid with a secondary amine.
The conversion of 3-keto steroids into the I: namine derivatives is a valuable method for blocking the 3-keto group; the 3-keto group can be regenerated easily and with high yield by simple hydrolysis after further conversions have been carried out in the steroid molecule.
The subject of the present patent is a process for the production of 3-Ket.o-oxysteroids, which is characterized in that one 3-keto-steroids, which contain at least one further carbonyl group in the molecule, by reaction with a secondary amine, preferably pyrrolidine, converts into the corresponding 3-dnamine derivatives, in which the free carbonyl groups are reduced to Ilydroxylgruppen, preferably with lithium-aluminum hydroxide,
and in the enamine derivatives thus obtained, the 3-keto group is restored by hydrolysis.
If lithium aluminum hydride is used as the reducing agent, the restoration of the 3-keto group usually takes place simultaneously with the decomposition of the complex compound formed during the reduction.
For example, the physiologically active hormone testosterone can be produced from 4-androstene-3,17-dione via the enamine derivative by converting the 4-androstene-3,17-dione into the 3- (N-pyrrolidyl) -3,5-androstadien-17- converted and in the ketone protected in this way, the 17-keto group is reduced to the 17-oxy group.
If the 3-keto group is then regenerated in 3- (N-pyrrolidyl) -3,5-androstadien-17-ol, 4-androsten-17-ol-3-one, i.e. testosterone, is obtained. When using 3-keto steroids with additional keto groups at any other point in the molecule, one can proceed in the same way.
The starting materials can in the core further substituents such. B. oxy, acyloxy, carbalkoxy groups, etc., carry, which are located on one or more of the carbon atoms of the core, z. B. in position 7, 11, 12, 17 or other positions can be. In addition, the nucleus can form double bonds. These double bonds can be isolated or conjugated and can also be conjugated to the carbonylsaiierstoffatom in the 3-position.
If a 4 (5) double bond is present, the 4 (5) double bond shifts to the 5 (6) position during the reaction. In the 17-position of the core there may be a side chain, e.g. B. such as occurs in natural steroids, such as in the sterols, bile acids and pregnanes, or one obtained from such by substitution or partial degradation.
Examples of such ketosteroids which can be used as starting materials are, for example, sterols such as cholestane-3,6-dione, 11-keto-progesterone, pregnane-3,20-dione, pregnane-3,11,20-trione, cortisone , 21-acyloxy-17aoxy-pregnane-3,11,20-trione, androstane-3,17-dione, 4-androstene-3,17-dione.
The enamine derivatives are preferably obtained by heating the 3-keto-steroid with the secondary amine in an organic solvent with continuous removal of the water formed during the reaction. The water can be distilled by azeotropic De or by means of a basic, inorganic, water-binding compound, such as potassium carbonate, calcium or barium oxide and the like.
Such enamines are formed at temperatures between about 25 and about 150 ° C., preferably between 40 and 110 ° C., expediently at the reflux temperature of the reaction mixture, but always below the decomposition temperature of the end product, i.e. of the enamine. The reaction time varies depending on the reactivity of the amine and the reaction temperature. A reaction time of from 30 minutes to 20 hours is usually advantageous in the preferred temperature range.
The preferred amount of secondary amine is 4 moles of amine per mole of steroid; but you can generally with. Amounts of about 1-20 moles of amine or more will work. Suitable solvents are diethyl ether, tetrahydrofuran, an excess of the amine, benzene, xylene, toluene, pentane, ilexamine and the like.
An acid catalyst such as p-toluenesulfonic acid, naphthalenesulfonic acid, sulfuric acid and the like can be added to promote the reaction and increase the yield, with p-toluenesulfonic acid being usually preferred. Sometimes, especially when the amine is hard to react, you can work in a bomb using pressure.
As secondary amines, dialkylamines such as diethylamine, dipropylamine, di-butylamine, dihexylamine, dioctylamine and di-dodecylamine can be used; Cycloalkylamirie, such as Diey clohexylamine and the like;
Cyclic amines such as piperidine, pyrrolidine, tetrahydroehinoline, oxazolidine (tetrahydrooxazole), chlorophyllur and the like; Aralkylalkylamines such as N-methyl-1-benzylamine, N-aryl-benzylamine and the like; substituted dialkylamines such as diethanolamine and the like;
and arylalkylamines such as. Use N-141ethyl-aniline, N-3-ethyl-toluidine, N-methyl-anisidine, and the like.
<I> Example. </I> a) A solution of 8.58 g (0.3 mol) 4-androstene-3,17-dione and 10.02 cm3 (0.12 mol) pyrrolidine in 150 em3 benzene is dissolved in a flask with a reef-flow bucket and water catcher heated vigorously for 3 hours on the re-flow while stirring, after which time the theoretical amount of water has been collected.
The solution is then evaporated to dryness in vacuo and the yellow, crystalline residue is triturated with 50 cm3 of methanol. After cooling for six hours at 4 C, it is filtered, washed with 23 cubic meters of cold methanol and dried.
The yield of 3- (N-pyrrolidyl) -3,5-androstadien-17-one is 9.15 g (90 / o). b) A solution of 3.8 g (0.10 111o1) lithium aluminum hydride in 1600 em3 anhydrous ether is placed in a Soxhlet flask, and 6.09 g (0.018) hol) 3- (N) are placed in the extraction cartridge -Pyrrolidyl) -3,
5-androstadien-17-one. Then it is heated to reflux. The condensed returning vapors dissolve the steroid and bring it into the flask, where the reduction takes place. After 45 minutes, all steroid is dissolved. The mixture is cooled, carefully decomposed by adding 10 cm3 of water and extracted with benzene. The benzene solution is dried and evaporated.
5.25 g (86 "/ m) of crude 3- (N-pyrrolidyl) -3,5-androstadien-17ss-ol are obtained. A sample recrystallized from methylene chloride-methanol gives yellow needles with a melting point of 133 to 137 C: Analysis: / oa calculated for Cz3H35ON: N 4.13 found:
N 4.07 e) A solution of 4.25 g of 3- (N-pyrrolidyl) -3,5-androstadien-17ss-ol (prepared as described under b), 7.5 g -, atrium acetate, 8 cin3 Water and 2 cubic meters of concentrated hydrochloric acid in 150 cubic meters of methanol - is refluxed:; Cooked for hours. The solution is then diluted with 200 cubic meters of water, cooled and the precipitated testosterone is filtered off. The latter is with.
Washed water and get.rock- i) et. The yield is 2.04 g (73%); Melting point 149-150 C).
Same as in the previous one. For example, starting from other 3-keto-steroids with additional carbonyl groups, one can arrive at the corresponding 3-keto-oxysteroids, which can already be physiologically active steroid hormones or can be converted into active compounds.
For example, from 3- (N-pyrrolidyl) -3,5-androstadiene-11,17-dione and from 3- (N-pyrroliclyl) -3,5-pregnadien-lla-ol-20-one by reducing with lithium aluminum hydride or other reducing agents and restoring the 3-keto group by acidic droolysis of the 11 ', - Oxv-testosterone or
the 11a, 20- I) ioxy -4-pregnen-3-one.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US331998XA | 1952-05-17 | 1952-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH331998A true CH331998A (en) | 1958-08-15 |
Family
ID=21869049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH331998D CH331998A (en) | 1952-05-17 | 1953-05-12 | Process for the preparation of 3-keto-oxysteroids |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH331998A (en) |
-
1953
- 1953-05-12 CH CH331998D patent/CH331998A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE951569C (en) | Process for the production of enamines | |
| DE1468410A1 (en) | Process for the preparation of 16-methylene steroids | |
| CH331998A (en) | Process for the preparation of 3-keto-oxysteroids | |
| DE1222920B (en) | Process for the preparation of 19-methylene derivatives of the androstane series which are substituted in the 3-position by an oxygen-containing substituent | |
| CH494216A (en) | Process for the preparation of 6-aminomethyl-3,5-steroids bearing an etherified hydroxyl group in the 3-position | |
| DE960817C (en) | Process for the preparation of 3-keto steroids | |
| DE2617295A1 (en) | METHOD OF MANUFACTURING SPIRAL COMPOUNDS OF THE STEROID SERIES | |
| DE954695C (en) | Process for the production of enamines | |
| AT233179B (en) | Process for the preparation of the new 3β-hydroxy- and 3β-acyloxy-6, 16-dimethylpregna-5, 16-dien-20-one | |
| DE19631543C1 (en) | 3-Sulphatoxy-oestra-1,3,5(10)-tri:ene derivatives preparation | |
| AT232203B (en) | Process for the preparation of 3β-hydroxy-6-methyl-Δ <5> -steroids | |
| DE940826C (en) | Process for the preparation of substituted trans-anti-trans-13-methyl-perhydrophenanthren-1-one compounds | |
| DE871150C (en) | Process for the preparation of new alicyclic ketones | |
| DE953343C (en) | Process for the hydrolysis of steroid 3-enamines | |
| DEU0002194MA (en) | ||
| DE962884C (en) | Process for the preparation of pregnan- 11ª ‰, 17ª ‡ -diol-3, 20-dione | |
| AT270884B (en) | Process for the preparation of new 4,6-pregnadiene derivatives | |
| DE1187236B (en) | Process for the preparation of 17beta-amino steroids | |
| DE1300561B (en) | Process for the production of unsaturated steroid lactones | |
| AT339514B (en) | METHOD FOR MANUFACTURING NEW 15ALFA, 16ALFA-METHYLENE-4-OSTRENE-17BETA-OLEN | |
| DE1618859C (en) | Process for the production of 3 keto lObeta methyl llbeta hydroxy Delta to the power of 4 steroids | |
| DEU0003188MA (en) | ||
| CH618705A5 (en) | Process for the preparation of spiro compounds of the steroid series. | |
| DE1047198B (en) | Process for the preparation of 11ª ‰, 21-dioxy-4,6,17 (20) -pregnatrien-3-ones and their 21-acylates | |
| DEU0003461MA (en) |